What is Novarad?
Founded in 1990 by Dr. Wendell Gibby, Novarad has evolved from a niche radiology startup into a comprehensive healthcare IT and imaging solutions provider. Headquartered in American Fork, Utah, the company specializes in the development of sophisticated software systems designed to streamline clinical workflows and enhance diagnostic accuracy. Their product portfolio, which includes advanced PACS and enterprise imaging platforms, serves as a critical backbone for hospitals and diagnostic centers seeking to modernize their digital health architecture. Novarad maintains a strong market position by balancing legacy reliability with continuous innovation in imaging informatics.
How much funding has Novarad raised?
Novarad has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Novarad
PPP
Public-Private Partnership
What's next for Novarad?
With the recent influx of capital, Novarad is positioned to accelerate its research and development initiatives, particularly in the integration of artificial intelligence within its existing imaging suites. The strategic roadmap likely involves scaling its enterprise-level solutions to meet the increasing demand for interoperable health data systems. As the healthcare industry shifts toward more integrated, cloud-native diagnostic environments, Novarad is well-equipped to leverage its deep domain expertise to capture additional market share. This financing round serves as a catalyst for long-term growth, enabling the firm to refine its product offerings and maintain its competitive edge against emerging health-tech disruptors.
See full Novarad company page
